Congenica
Genomic data analysis platform for rare diseases and cancer.
About
Congenica offers a clinical genomic interpretation platform that transforms raw sequencing data into actionable clinical insights for rare disease, oncology, and infectious diseases. Born from the Wellcome Sanger Institute and now part of the SeqOne family, their AI-powered platform is trusted by over 190 labs in 35+ countries and supports national programs like Genomics England and the NHS. Congenica serves laboratories and clinicians by accelerating the delivery of personalized medicine at scale. Teams look it up for HealthTech, MedTech, Genomics.
Frequently asked
What does Congenica do?
Congenica is a HealthTech company that offers Platform. Teams look it up for MedTech, Genomics, Drug Discovery. It is based in Cambridge, United Kingdom and was founded in 2013. Public records show $74M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Congenica raised?
Congenica has raised a total of $74M in funding.
Where is Congenica headquartered?
Congenica is headquartered in Cambridge, United Kingdom.
When was Congenica founded?
Congenica was founded in 2013.
What industry does Congenica operate in?
Congenica operates in HealthTech, MedTech, Genomics, Drug Discovery, Clinical Trials.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.